"Understanding USP 71 Sterility Tests and Extending BUD"

Similar documents
STERILITY TESTING OF PHARMACEUTICAL PRODUCTS

Microbiological Quality of Non-sterile Products Culture Media for Compendial Methods

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES

Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective

Product Sterility Testing... To Test or Not to Test? That Is the Question

Laboratorios CONDA, S.A. Distributed by Separations

A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW

247 CMR BOARD OF REGISTRATION IN PHARMACY

Compounding Medication Regulations

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts

USP <797> Overview and Compliance Audit Results. Joseph W. Coyne RPh Director of Field Operations Clinical IQ, LLC

Ingredient Listing Qty. Unit NDC # Supplier g

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph..

Media Fill Test Kits. Manufactured by. Making USP <797> compliance easy!

1 INJECTIONS INTRODUCTION

This chapter provides tests for the estimation of the numble, a suitable, validated adaptation of a procedure set forth

2013 USP Chapter <797> Compliance Survey & Current Practice Standards

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

Legal Aspects in Intravenous Nutrient Therapy. Nayan Patel PharmD

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations

Lidocaine Hydrochloride 2%, Metronidazole 2%, Misoprostol % Topical Ointment (Suspension, 30 g) Ingredient Listing Qty. Unit NDC # Supplier

BRIEFING 1 INJECTIONS INTRODUCTION

Ingredient Listing Qty. Unit NDC # Supplier TBD. Sterile Preparation

1 INJECTIONS INTRODUCTION

The Therapeutic Goods Act (1989)

SCOPE AND FIELD OF APPLICATION

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES

New TGA Requirements for Microbiology

A high-level overview of the requirements of medical packaging standards

Evaluation of antimicrobial effectiveness of ophthalmic drops according to the pharmacopeial tests criteria

I.C.E. Embryo Vitrification Kit

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier ml

HARMONISED PHARMACOPOEIA DEHYDRATED CULTURE MEDIA FOR SUPPORTING REGULATORY COMPLIANCE AVAILABLE NOW P O RTF O LIO.

Technical Report No. 75 Consensus Method for Rating 0.1µm Mycoplasma Reduction Filters

Survival of Aerobic and Anaerobic Bacteria in

Quality. Guaranteeing High Quality. Outsourced Pharmacy Services. Disclosure 3/18/2013

Ingredient Listing Qty. Unit NDC # Supplier

Hydrocortisone 2%, Hydroquinone 6%, Kojic Acid 4%, Salicylic Acid 4%, Tretinoin 0.01% Topical Gel (Suspension, 20 g)

PDA Points to Consider relating to EU GMP Annex 1 changes. Presented by Ashley Isbel 30 November, 2016

History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products

Ingredient Listing Qty. Unit NDC # Supplier

Draft Guidance for Industry and FDA Staff

3.7 Bracketing. 3.8 Matrixing

Vimta Labs Ltd., Life Sciences Facility, Plot No. 5, Alexandria Knowledge Park, Genome Valley, Shameerpet, Hyderabad, Telangana

See external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

October 26-30, 2003 Salt Lake City, Utah

The Sterility of Reusable Instruments at Central Surgery Installation s Room Storage of One of The Hospital in Bandung

Preservation of Food. H4.2: Applies principles of food preservation to extend the life of food and maintain safety.

SUGGESTED FORMULATION. Lot Number. Expiry Date. Ingredient Listing Qty. Unit NDC # Supplier

UNIT I EVOLUTION OF THE PHARMACY

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

Rapid Sterility Testing Edited by Jeanne Moldenhauer

Wipe Kit. For addressing <USP 800> Hazardous Drugs - Handling in Healthcare Settings

TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ USA SAMPLE DESCRIPTION : LIP GLOSS STYLE / ITEM NO.

ENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)

Misconceptions with Moist Heat Sterilization Roy McLean

Ingredient Listing Qty. Unit NDC # Supplier g. Sterile Preparation

How Do You Know If a Sterilized Package Remains Sterile?

Stability Of Extemporaneously Prepared Oral Liquid Formulations Part XI

How Do You Know If Your Sterilized Instruments Remain Sterile?

Mt. San Antonio College Microbiology 22 Lab Schedule for Spring 2018 Tues/Thurs. Split Lab Sections ONLY

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope

ISO INTERNATIONAL STANDARD. Sterilization of health care products Radiation Part 2: Establishing the sterilization dose

Stability of levetiracetam oral solution repackaged in oral plastic syringes

Open Microphone Session on USP General Chapter <825> Radiopharmaceuticals Preparation, Compounding, Dispensing, and Repackaging

Lab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1

Stonegate Pharmacy LP 11/10/16

H.Pylori IgM Cat # 1504Z

Healthcare Sterilisation: Introduction and Standard Practices, Volume 1

Town and Country Compounding and Consultation Services, LLC 10/17/17

TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ USA SAMPLE DESCRIPTION : HAND SANITIZER BUDDY WITH HAND SANITIZER

Allergy Vial Preparations and USP 797. Donald W Aaronson MD JD MPH

Model Standards for Pharmacy Compounding of Non-Sterile Preparations

Experience of paediatric formulations in Marketing Authorisatrion Applications

Sterilization of health care products Radiation. Part 2: Establishing the sterilization dose

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate

3/2/2018. Christopher M. Dembny R.Ph. Dembny Pharmacy Consultants LLC Learning Objectives. Rule Compliance is Stimulating

גדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.

SCAN RDI PROTOCOLS FOR ENVIRONMENTAL MONITORING

PARENTERAL PREPARATIONS

Evaluation of a Waterless, Scrubless Chlorhexidine Gluconate/Ethanol Surgical Scrub for Antimicrobial Efficacy

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017

Environmental Monitoring How to Satisfy the Regulator. Presented by Tanja Varglien, July 2017

H.pylori IgA Cat #

Food Contamination and Spoilage Food Safety: Managing with the HACCP System Second Edition (245TXT or 245CIN)

905 UNIFORMITY OF DOSAGE UNITS

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries.

Parametric Release Regulatory Requirements. Terry E. Munson Technical Vice President PAREXEL International, LLC

[ 11 C]Mes-IMPY FOR INJECTION: CERTIFICATES OF ANALYSIS

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20

H.Pylori IgG Cat # 1503Z

The USP and Compounding Nonsterile Medications

Microbial quality of some herbal solid dosage forms

Transcription:

"Understanding USP 71 Sterility Tests and Extending BUD" ERIC S. KASTANGO, M BA, RPH, FASHP CLINICAL IQ, LLC JULY 10, 2013

Disclaimer Although I am an Expert Consultant to the USP, I am speaking today in my individual capacity and not as a member of the Committee or as a USP representative. The views and opinions presented are entirely my own. They do not necessarily reflect the views of USP or any other organization I may be associated with, nor should they be construed as an official explanation or interpretation of <797>. ClinicalIQ content 2013, ClinicalIQ, LLC 2

Understanding BUD Recognizes the probability of contamination even under best conditions: Optimal employee performance 0.1% (1 contaminated dose out of 1,000) Contamination rates published in the literature 0.3% 16% Patient Safety: Protect patients from dangerous or even fatal overgrowths of microorganisms that may have been accidentally introduced Storage time: needs to be greater than zero but less than positive infinity* (> 0 and < + ) * Personal conversation with Dr. David W. Newton, September 30, 2009 ClinicalIQ content 2013, ClinicalIQ, LLC

Understanding BUD For patient safety, BUD must be based on two factors: Drug s chemical stability in conjunction with Microbiological limits BUD will always be whichever is shorter Must factor in chemical stability Concern that microbial over-colonization of solutions would occur over time. ph of solution is a consideration Neutral (ph 6-8) favorable for microbial colonization ClinicalIQ content 2013, ClinicalIQ, LLC

Microbiological Beyond-Use Dating Risk Category Room Temp Refrigerator Freezer ( -10 C) Immediate Use 1 hour 1 hour N/A Low 48 hours 14 days 45 days Low w/12-hr BUD 12 hours or less 12 hours or less N/A Medium 30 hours 9 days 45 days High 24 hours 3 days 45 days ClinicalIQ content 2013, ClinicalIQ, LLC

Sterility Testing Only required when USP <797> BUD limits are exceeded or when more than 25 units of HR CSPs are prepared. NO testing is required for any risk-level CSP prepared if handled within the limits, terms and conditions described in USP Chapter <797> ClinicalIQ content 2013, ClinicalIQ, LLC

Process Simulation Testing (PST) It is only a point-in-time representation of: The environment The equipment The procedure The personnel involved Test Media for Suitability Sterility Growth Promotion After the incubation period is complete USP FAQs Does not recognize PST as a means of extending BUD ClinicalIQ content 2013, ClinicalIQ, LLC

Non-Visibility of Microbial Contamination Numbers of Bacteria per ml in 1L bottles Millipore Corp. Hospital Pharmacy Filtration Guide (Cat. No. MP801) Bedford, MA; 1980:3 ClinicalIQ content 2013, ClinicalIQ, LLC

What is Sterility? Free from bacteria or other microorganisms American Heritage's Definition of Sterility Within the strictest definition of sterility, a specimen would be deemed sterile only when there is complete absence of viable microorganisms from it. <1211> Sterilization and Sterility Assurance of Compendial Articles Is it possible to demonstrate complete absence of microorganisms from a CSP? Absolute sterility can t be demonstrated without the complete destruction of every article from the lot of CSPs. ClinicalIQ content 2013, ClinicalIQ, LLC 9

Critical Concepts of Sterilization Sterility Assurance Level (SAL) is the probability of a nonsterile item making it through the validated sterilization process. Items terminally sterilized by moist or dry heat, irradiation, or chemical sterilants have a SAL of 10-6 1 nonsterile item per 1 million items sterilized Items prepared aseptically with a 0.22 micron filter have a SAL of 10-3 1 nonsterile item per 1 thousand items sterilized ClinicalIQ content 2013, ClinicalIQ, LLC

Standard of Sterility <1> Injections Parenteral articles are prepared.to ensure they meet pharmacopeial requirements for sterility, pyrogens,... Sterility Tests Preparations for injection meet the requirements under Sterility Tests <71> ClinicalIQ content 2013, ClinicalIQ, LLC

Standard of Sterility Aseptic Processing from USP Chapter <1211>: While there is general agreement that sterilization of the final filled container as a dosage form or final packaged device is the preferred process for assuring the minimal risk of microbial contamination in a lot, there is a substantial class of products that are not terminally sterilized but are prepared by a series of aseptic steps. ClinicalIQ content 2013, ClinicalIQ, LLC

Probability The sterility of a lot purported to be sterile is therefore defined in probabilistic terms, where the likelihood of a contaminated unit or article is acceptably remote. ClinicalIQ content 2013, ClinicalIQ, LLC

Sterility Testing USP <71> Sterility Tests states: These Pharmacopeial procedures are not by themselves designed to ensure that a batch of product is sterile or has been sterilized. This is accomplished primarily by method suitability of the sterilization process or of the aseptic processing procedure. ClinicalIQ content 2013, ClinicalIQ, LLC

Understanding all of the elements Risk Level Beyond-Use Dating (point in time) Chemical Stability Microbial Stability Aseptic technique ASSUMPTION! CSP is stored at its optimal temperature at all times. Due to the inherent low probability that a Sterility Test can detect low levels of contamination in a batch, sterility assurance must always be based on process design and control. ClinicalIQ content 2013, ClinicalIQ, LLC

USP <71> Sterility Tests Scott Sutton, Ph.D. scott.sutton@microbiol.org 41

Disclaimer I am making this presentation as an independent agent I am not making this presentation as a representative of USP, PDA, PMF or any other organization with which I am currently associated. The views expressed in this presentation are offered as mine alone. 2

Overview of Presentation Who Cares? What are the compendial Sterility Tests? Product Requirements Method Suitability 3

FDA Apothecure - 03/18/2013 The Compounding Shop - 03/18/2013 Central Admixture Pharmacy Services, Livonia, Wallingford, Woburn 483 Issue Green Valley Drugs - 03/11/2013 Olympia Pharmacy - 03/04/2013 Medasus 3/18/13 Sterility Failures & Investigation Sterility Test non-compliant No sterility testing performed Sterility testing not performed on all batches Investigation of Sterility Test failures Sterility testing not performed on all batches Sample size for Sterility testing No sterility testing on finished product Bulk product released for dispensing before sterility test complete MedPREP Consulting, Inc - 3/15/13 Sterility testing not performed on all batches Investigation of Sterility Test failures Nora Apothecary and Alternative Therapies, Inc. 3/19/13 Sterility testing not performed on all batches 4 Investigation of Sterility Test failures

FDA Sutton, S. 2013. GMP and Compounding Pharmacies. Amer Pharm Rev. 16(3):48-59. http://www.americanpharmaceuticalreview.com/featured -Articles/135985-GMP-and-Compounding-Pharmacies/ 5

The Press 6

Overview of Presentation Who Cares? What are the compendial Sterility Tests? Product Requirements Method Suitability 7

Sterility Testing Two separate tests Membrane Filtration Direct Transfer 20 Units, 2 media & temperatures Requires Growth Incubation period - 14 days Moldenhauer, J and S. Sutton. 2004. Towards an Improved Sterility Test. PDA J of Science and Technology 58(6):284-286. 8

Membrane Filtration Filter required amount of product through two filters Neutralize/Rinse 3 100 ml volumes suggested Formulations for dilution fluids suggested One filter into Soybean Casein Digest Broth (SCDB or TSB) incubate at 20-25 o C for 14 days One filter into Fluid Thioglycollate Medium (FTM) incubate at 30-35 o C for 14 days 9

Direct Inoculation Place required amount of product into sufficient recovery medium (with neutralizers?) Soybean Casein Digest Broth (SCDB or TSB) incubate at 20-25 o C for 14 days Fluid Thioglycollate Medium (FTM) incubate at 30-35 o C for 14 days 10

Product Requirements Minimum Quantity per Unit for Each Medium Liquids Minimum Quantity < 1 ml The whole contents of each container 1-40 ml Half the contents of each container, but not less than 1 ml >40 - <100 ml 20 ml per container >100 ml 10% of the contents of the container, but not less than 20 ml Antibiotic Liquids 1 ml 11

Product Requirements Minimum Quantity per Unit for Each Medium Solids Minimum Quantity < 50 mg The whole contents of each container 50 - <300 mg Half the contents of each container, but not less than 50 mg 300 mg 5 g 150 mg per container >5 g 500 mg per container Insoluble preparations, creams, and ointments to be suspended or emulsified - Use the contents of each container to provide not less than 200 mg 12

Number of Units to be Tested 13

Example 1-84 units of 10 ml 10 ml is between 1 and 40 ml Table 2 tells us to use ½ volume or 5 ml per unit 84 units is less than 100 Table 3 tells us to use the greater of 4 units or 10% of the batch = 8 units per medium We therefore must test at least 5 ml from each of 8 units for each medium 14

Example 2 6 units of 1.5 ml 1.5 ml is between 1 and 40 ml Table 2 tells us to use ½ volume but not less than 1 ml therefore we test 1 ml ml per unit 6 units is less than 100 Table 3 tells us to use the greater of 4 units or 10% of the batch = 4 units per medium We therefore must test at least 1 ml from each of 4 units for each medium. 15

Overview of Presentation Who Cares? What are the compendial Sterility Tests? Product Requirements Method Suitability 16

Method Suitability Test Can we neutralize any antimicrobial properties of the medication? Use specified challenge organisms Use specified total amounts of products 17

Method Suitability Test for Each Challenge Organism Filter maximal amount of medication to be tested Filter 2 volumes (100 ml?) of diluting fluid Add third volume, inoculate with <100 CFU challenge organism Filter Show microbial growth from filter in relevant medium at relevant temperature in 5 days 18

Method Suitability Test 6 challenge organisms FTM C. sporogenes P. aeruginosa S. aureus SCDB A. brasiliensis B. subtilis C. albicans 19

Method Suitability Examples Example 1-84 units of 10 ml 5 ml from 8 units = 40 ml for each organism; there are 6 6 x 40 ml = 240 ml total for Method Suitability Example 2 6 units of 1.5 ml 1 ml from 4 units = 4 ml for each organism 6 x 4 ml = 24 ml total for Method Suitability 20

Review of Presentation Who Cares? What are the compendial Sterility Tests? Product Requirements Method Suitability 21

Thank you for your attention Scott Sutton, Ph.D. scott.sutton@microbiol.org +1 585-298-0767 (cell) http://www.linkedin.com/in/scottvwsutton @MicrobiologyNet